Active, not recruitingPhase 2NCT01025089
Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
Studying Thymoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- James Huang, MDMemorial Sloan Kettering Cancer Center
- Intervention
- Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide(drug)
- Enrollment
- 18 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2026
Study locations (8)
- City of Hope Medical Center, Duarte, California, United States
- Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
- Memorial Sloan Kettering West Harrison, Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
- Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States
- Md Anderson Cancer Center, Houston, Texas, United States
Collaborators
Eli Lilly and Company · M.D. Anderson Cancer Center · City of Hope National Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01025089 on ClinicalTrials.govOther trials for Thymoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06730308Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable ThymomaSun Yat-sen University
- RECRUITINGNANCT06029621Robot-assisted vs VATS for ThymomaShanghai Pulmonary Hospital, Shanghai, China
- ACTIVE NOT RECRUITINGNANCT05682742Clinical Investigation of the da Vinci Surgical SystemIntuitive Surgical
- RECRUITINGNANCT02633553Adjuvant Radiotherapy for Stage II/III Thymoma After Complete ResectionFudan University
- ACTIVE NOT RECRUITINGPHASE2NCT03076554A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based ChemotherapyNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNANCT03968315An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent ThymomaM.D. Anderson Cancer Center